Financials

v3.25.1
BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 2,831 $ 6,760
Restricted cash 13
Receivables, net 46
Notes receivable 1,000
Related party receivable 62
Prepaid expenses and other current assets 30 199
Total current assets 2,923 8,018
Property and equipment, net 5
Operating lease right-of-use asset 63
Total assets 2,923 8,086
Current liabilities:    
Accounts payable 202 348
Note payable to related party 500
Other accrued liabilities 281 519
Operating lease liability, current 65
Deferred grant revenue 12
Total current liabilities 483 1,444
Total liabilities 483 1,444
Stockholders’ equity:    
Preferred stock, at amounts paid-in, $0.001 par value per share; 5,000,000 shares authorized, 950,000 shares issued and outstanding at December 31, 2024 and 2023. 1 1
Common stock, at amounts paid-in, $0.001 par value per share; 225,000,000 shares authorized, 914,234 and 781,503 shares issued and outstanding at December 31, 2024 and 2023, respectively. 1 1
Additional paid-in capital 398,974 398,470
Accumulated deficit (396,536) (391,830)
Total stockholders’ equity 2,440 6,642
Total liabilities and stockholders’ equity $ 2,923 $ 8,086

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL
v3.25.1
STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Total revenues $ 184
Operating expenses:    
Research and development 1,913
General and administrative 4,557 5,548
Total operating expenses 4,557 7,461
Loss from operations (4,557) (7,277)
Other income (expense):    
Interest income, net 1 5
Other expense, net (150) (52)
Gain on asset sale 1,755
Other income (expense), net (149) 1,708
Net loss $ (4,706) $ (5,569)
Basic net loss per common share $ (5.23) $ (7.41)
Diluted net loss per common share $ (5.23) $ (7.41)
Weighted average shares used in computing basic net loss per common share 899 752
Weighted average shares used in computing diluted net loss per common share 899 752
License and Service [Member]    
Total revenues $ 1
Grant [Member]    
Total revenues $ 183

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL
v3.25.1
STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (4,706) $ (5,569)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5 112
Gain on sale of assets (1,755)
Stock-based compensation 1,013
Amortization of restricted stock 25
Other (2) (2)
Changes in operating assets and liabilities:    
Receivables, net 46 (10)
Notes receivable 1,000
Prepaid expenses and other current assets 169 177
Accounts payable (145) (476)
Other accrued liabilities (235) (423)
Deferred grant revenue (12) (184)
Net cash used in operating activities (3,880) (7,092)
Cash flows from investing activities:    
Cash proceeds from sale of assets 734
Purchases of furniture and equipment (2)
Net cash provided by investing activities 732
Cash flows from financing activities:    
Proceeds from issuance of preferred stock 9,500
Payments on behalf of related party (62)
Proceeds from short-term loans 750
Payments on short-term loans (250)
Net cash provided by (used in) financing activities (62) 10,000
Net change in cash and restricted cash (3,942) 3,640
Cash and restricted cash at beginning of year 6,773 3,133
Cash and restricted cash at end of year 2,831 6,773
Supplemental disclosure of cash flow information:    
Interest paid 13 21
Inventory transferred with sale of assets 106
Property and equipment, net, transferred with sale of assets 109
Notes receivable received in connection with sale of assets 1,000
Note payable converted to common stock 500
Other accrued liabilities transferred with sale of assets 236
Accrued interest net of tax converted to common stock 4
Other accrued liabilities related to stock-based compensation 310
Cash 2,831 6,760
Restricted cash 13
Cash and restricted cash as shown in the statements of cash flows $ 2,831 $ 6,773

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL